Delivery Order SPE2DB22D2006-SPE2DB25FW4ED
- Not listed
- The Defense Logistics Agency awarded a $1,089.54 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension in 7.5mL units. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for ultimate completion on August 13, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,569.12 firm fixed-price delivery order on August 28, 2025, for Ciprofloxacin-Dexamethasone otic suspension in 7.5ml units, with completion scheduled for August 29, 2025. This delivery order, which carries no set-aside designation, represents a competitively awarded transaction under the company's larger contract vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,574.71 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5ML) on August 7, 2025, with an ultimate completion date of August 8, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,780.32 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5ML) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, with a ceiling value of $1,272.60 and completion deadline of August 14, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of AmerisourceBergen's established role as a critical pharmaceutical supplier to the Department of Defense. The contract carries no set-aside designation...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ml, with a ceiling value of $1,692.67. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, and is scheduled for completion by August 15, 2025. The award represents a small-value pharmaceutical procurement typical of the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,451.13 for Ciprofloxacin-Dexamethasone otic suspension (7.5mL) on July 23, 2025, with completion scheduled for July 24, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5 mL) with a ceiling value of $4,619.58. This contract is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and carries no set-aside designation, indicating it was competitively awarded. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $1,097.53 delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) under a firm fixed price contract type. The award, issued on August 5, 2025, with completion targeted for August 6, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply delivery. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,832.00 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone otic suspension in 7.5 mL units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 19, 2025. The award was issued on August 18, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction within...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW4EDDelivery Order
The Defense Logistics Agency awarded a $2,524.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Ciprofloxacin-Dexamethasone otic suspension in 7.5mL units. The contract, classified as a delivery order with no set-aside designation, carries an ultimate completion date of September 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award represents a competitively awarded transaction consistent with AmerisourceBergen's extensive federal procurement portfolio. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999 global pharmaceutical support vehicle running through December 2026. The parent contract serves as a comprehensive vehicle enabling the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract awards demonstrate its established capability as a critical pharmaceutical distributor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with a proven track record of delivering diverse pharmaceutical commodities ranging from specialty medications to generic drugs and medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 9/12/25 |